Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

The presence of inflammation on liver biopsy is associated with the development of advanced fibrosis in NASH. The presence of acinar inflammation is essential for the histological diagnosis of ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

[53–55] Similarly, animal models of high-fat diet-induced insulin resistance and NAFLD are typically without hepatic inflammation. Nonalcoholic steatohepatitis (NASH) is a common disease that ...

Roche’s Genentech unit bought Jecure Therapeutics and its portfolio of NLRP3 drugs in 2018, focusing on peripheral drugs for NASH, liver fibrosis, gout, inflammatory bowel disease, and ...

Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues ...

In the phase 2b trial lanifibranor met twin endpoints relating to inflammation resolution and ... doses producing significant improvements in NASH resolution without worsening of fibrosis ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

HC Wainwright reissued their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a report published on Friday,Benzinga reports. HC Wainwright currently has a $13.00 price target on the stock ...

PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a review in the Journal of Endocrinology. Credit not just the weight loss but ...